Cover Image

Thioether derivatives of 1,2,3-triazole-N-oxides: Synthesis, study of cytotoxicity and cellular nitric oxide (NO) production effect

Vsevolod V. Melekhin, Maria D. Tokhtueva, Igor A. Lavrinchenko, Nikita O. Matyushin, Timofey D. Moseev, Mikhail V. Varaksin, Valery N. Charushin, Oleg N. Chupakhin

Abstract


In this work, a synthetic strategy based on the reaction of 5-bromo-2-(4-fluorophenyl)-4-methyl-2H-1,2,3-triazole with various thioaromatic derivatives were applied to afford a series of thioether derivatives of 1,2,3-triazole-N-oxides in yields of 52–80%. The obtained compounds were shown to be characterized by low cytotoxicity towards human embryonic kidney (HEK293) cells with IC50 values ranging from 128 to 76 µM and high toxicity towards malignant rhabdomyosarcoma cancer (Rd) cells with IC50 values ranging from 93 to 22 µM. These compounds were screened for the ability to induce nitric oxide production in cells via DAF-FM fluorescence. Several compounds demonstrated a twofold increase in nitric oxide levels relative to the control. Two leader molecules demonstrating the lowest cytotoxicity values and the effect on nitric oxide production in rhabdomyosarcoma cells were identified. Thus, the method could be considered as a convenient one for qualitative or semi-quantitative determination of nitric oxide in a screening process of large number of compounds to define lead molecules capable of influencing nitric oxide production.

Keywords


triazole; N-oxides; nitric oxide; fluorescent imaging; thioethers

Full Text:

PDF

References


Battinelli E, Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood. 2000;95(11):3451–3459. doi:10.1182/blood.V95.11.3451

Pappas G, Wilkinson ML, Gow AJ. Nitric oxide regulation of cellular metabolism: Adaptive tuning of cellular energy. Nitric Oxide. 2023;131:8–17. doi:10.1016/j.niox.2022.11.006

Faienza F, Rasola A, Filomeni G. Nitric oxide-based regula-tion of metabolism: Hints from TRAP1 and SIRT3 crosstalk. Frontiers in Molecular Biosciences. 2022;9:942729. doi:10.3389/fmolb.2022.942729

Chen K, Pittman RN, Popel AS. Nitric Oxide in the Vascula-ture: Where Does It Come From and Where Does It Go? A Quantitative Perspective. Antioxidants & Redox Signaling. 2008;10(7):1185–1198. doi:10.1089/ars.2007.1959

Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-Arginine in Nitric Oxide Synthesis and Health in Hu-mans. In: Wu G, editor. Amino Acids in Nutrition and Health. Vol. 1332. Cham: Springer International Publish-ing; 2021 [accessed 2026 Jan 15]. p. 167–187. (Advances in Experimental Medicine and Biology). https://link.springer.com/10.1007/978-3-030-74180-8_10. doi:10.1007/978-3-030-74180-8_10

Forstermann U, Sessa WC. Nitric oxide synthases: regula-tion and function. European Heart Journal. 2012;33(7):829–837. doi:10.1093/eurheartj/ehr304

Marletta MA. Nitric oxide synthase: Aspects concerning structure and catalysis. Cell. 1994;78(6):927–930. doi:10.1016/0092-8674(94)90268-2

Rodnenkov OV, Rezukhina EA, Zorin AV, Lakomkin VL, Kapelko VI, Gramovich VV, Martynyuk TV. Therapeutic po-tential of nitric oxide pathway management in pulmonary arterial hypertension: from nitric oxide to its synthetic an-alog — Oxacom. Kardiologicheskii vestnik. 2022;17(4):24. doi:10.17116/Cardiobulletin20221704124

Abd El-Hay S, Colyer C. Development of High-Throughput Method for Measurement of Vascular Nitric Oxide Genera-tion in Microplate Reader. Molecules. 2017;22(1):127. doi:10.3390/molecules22010127

Li H, Förstermann U, Xia N, Kuntic M, Münzel T, Daiber A. Pharmacological targeting of endothelial nitric oxide syn-thase dysfunction and nitric oxide replacement therapy. Free Radical Biology and Medicine. 2025;237:455–472. doi:10.1016/j.freeradbiomed.2025.06.009

Balconi G; Dejana E. Cultivation of endothelial cells: limi-tations and perspectives. Medical Biology. 1986; 64(5): 231-245.

Koudelkova P, Weber G, Mikulits W. Liver Sinusoidal Endo-thelial Cells Escape Senescence by Loss of p19ARF. Calvisi D, editor. PLOS ONE. 2015;10(11):e0142134. doi:10.1371/journal.pone.0142134

Panneerselvan P, Vasanthakumar K, Muthuswamy K, Krishnan V, Subramaniam S. Insights on the functional du-alism of nitric oxide in the hallmarks of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(6):189001. doi:10.1016/j.bbcan.2023.189001

Jimenez J, Dubey P, Carter B, Koomen JM, Markowitz J. A metabolic perspective on nitric oxide function in melano-ma. Biochimica et Biophysica Acta (BBA) - Reviews on Can-cer. 2024;1879(1):189038. doi:10.1016/j.bbcan.2023.189038

Cunha IW, Lopes A, Falzoni R, Soares FA. Sarcomas Often Express Constitutive Nitric Oxide Synthases (NOS) But In-frequently Inducible NOS. Applied Immunohistochemistry & Molecular Morphology. 2006;14(4):404–410. doi:10.1097/01.pai.0000190175.98576.a3

Hagmann WK, Caldwell CG, Chen P, Durette PL, Esser CK, Lanza TJ, Kopka IE, Guthikonda R, Shah SK, MacCoss M, et al. Substituted 2-aminopyridines as inhibitors of nitric ox-ide synthases. Bioorganic & Medicinal Chemistry Letters. 2000;10(17):1975–1978. doi:10.1016/S0960-894X(00)00389-9

Connolly S, Aberg A, Arvai A, Beaton HG, Cheshire DR, Cook AR, Cooper S, Cox D, Hamley P, Mallinder P, et al. 2-Aminopyridines as Highly Selective Inducible Nitric Oxide Synthase Inhibitors. Differential Binding Modes Dependent on Nitrogen Substitution. Journal of Medicinal Chemistry. 2004;47(12):3320–3323. doi:10.1021/jm031035n

Silverman RB. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors for the Prevention and Treatment of Neurodegenerative Diseases. Accounts of Chemical Re-search. 2009;42(3):439–451. doi:10.1021/ar800201v

Poulos TL, Li H. Structural Basis for Isoform-Selective Inhi-bition in Nitric Oxide Synthase. Accounts of Chemical Re-search. 2013;46(2):390–398. doi:10.1021/ar300175n

Dzavik V, Cotter G, Reynolds HR, Alexander JH, Rama-nathan K, Stebbins AL, Hathaway D, Farkouh ME, Ohman EM, Baran DA, et al. Effect of nitric oxide synthase inhibi-tion on haemodynamics and outcome of patients with per-sistent cardiogenic shock complicating acute myocardial in-farction: a phase II dose-ranging study. European Heart Journal. 2007;28(9):1109–1116. doi:10.1093/eurheartj/ehm075

Gonzalez M, Clayton S, Wauson E, Christian D, Tran Q-K. Promotion of nitric oxide production: mechanisms, strate-gies, and possibilities. Frontiers in Physiology. 2025;16:1545044. doi:10.3389/fphys.2025.1545044

Kobus M, Friedrich T, Zorn E, Burmeister N, Maison W. Medicinal Chemistry of Drugs with N -Oxide Functionali-ties. Journal of Medicinal Chemistry. 2024;67(7):5168–5184. doi:10.1021/acs.jmedchem.4c00254

Schiefer IT, VandeVrede L, Fa’ M, Arancio O, Thatcher GRJ. Furoxans (1,2,5-Oxadiazole- N -Oxides) as Novel NO Mimet-ic Neuroprotective and Procognitive Agents. Journal of Me-dicinal Chemistry. 2012;55(7):3076–3087. doi:10.1021/jm201504s

Cai Y-M, Zhang Y-D, Yang L. NO donors and NO delivery methods for controlling biofilms in chronic lung infections. Applied Microbiology and Biotechnology. 2021;105(10):3931–3954. doi:10.1007/s00253-021-11274-2

Goldstein S, Lestage P. Chemical and Pharmacological As-pects of Heteroaryl-Nitrones. Current Medicinal Chemistry. 2000;7(12):1255–1267. doi:10.2174/0929867003374183

Lumeras W, Vidal L, Vidal B, Balagué C, Orellana A, Maldo-nado M, Domínguez M, Segarra V, Caturla F. 1,7-Naphthyridine 1-Oxides as Novel Potent and Selective In-hibitors of p38 Mitogen Activated Protein Kinase. Journal of Medicinal Chemistry. 2011;54(22):7899–7910. doi:10.1021/jm200975u

Ihsan A, Wang X, Tu H-G, Zhang W, Dai M-H, Peng D-P, Wang Y-L, Huang L-L, Chen D-M, Mannan S, et al. Genotox-icity evaluation of Mequindox in different short-term tests. Food and Chemical Toxicology. 2013;51:330–336. doi:10.1016/j.fct.2012.10.003

Tagat JR, Steensma RW, McCombie SW, Nazareno DV, Lin S-I, Neustadt BR, Cox K, Xu S, Wojcik L, Murray MG, et al. Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- me-thyl-4-[3( S )-methyl-4-[1( S )-[4-(trifluoro- me-thyl)phenyl]ethyl]-1-piperazinyl]- piperidine N 1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antago-nist. Journal of Medicinal Chemistry. 2001;44(21):3343–3346. doi:10.1021/jm0155401

Barriga G, Olea-Azar C, Norambuena E, Castro A, Porcal W, Gerpe A, González M, Cerecetto H. New heteroaryl nitrones with spin trap properties: Identification of a 4-furoxanyl derivative with excellent properties to be used in biological systems. Bioorganic & Medicinal Chemistry. 2010;18(2):795–802. doi:10.1016/j.bmc.2009.11.053

Lavrinchenko IA, Moseev TD, Varaksin MV, Seleznev YuA, Sadieva LK, Zyryanov GV, Tsmokaluk AN, Charushin VN, Chupakhin ON. Y-Shaped Fluorophores Based on N(2)-Aryl-1,2,3-triazoles: Synthesis and Study of Photophysical and Chemosensor Properties for the Detection of Nitroaromatic Compounds. Doklady Chemistry. 2023;512(1):232–241. doi:10.1134/S0012500823600682

Ganesh BH, Raj AG, Aruchamy B, Nanjan P, Drago C, Rama-ni P. Pyrrole: A Decisive Scaffold for the Development of Therapeutic Agents and Structure‐Activity Relationship. ChemMedChem. 2024;19(1):e202300447. doi:10.1002/cmdc.202300447

Mo X, Rao DP, Kaur K, Hassan R, Abdel-Samea AS, Farhan SM, Bräse S, Hashem H. Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024). Molecules. 2024;29(19):4770. doi:10.3390/molecules29194770

Frenkel-Pinter M, Bouza M, Fernández FM, Leman LJ, Wil-liams LD, Hud NV, Guzman-Martinez A. Thioesters provide a plausible prebiotic path to proto-peptides. Nature Com-munications. 2022;13(1):2569. doi:10.1038/s41467-022-30191-0

Constantinescu T, Lungu CN, Lung I. Lipophilicity as a Cen-tral Component of Drug-Like Properties of Chalchones and Flavonoid Derivatives. Molecules. 2019;24(8):1505. doi:10.3390/molecules24081505

Puchenkova OA, Shheblykina OV, Kostina DA, Bolgov AA, Lebedev PR, Molchanov VV, Pokrovskaya TG, Korokin MV, Nikiforov EA, Vaskina NF, et al. Study of acute toxicity, en-dothelial- and cardioprotective properties of phenolic and thiophenolic derivatives of 2H-imidazoles. Pharmacy & Pharmacology. 2025;12(6):394–409. doi:10.19163/2307-9266-2024-12-6-394-409

Nikiforov EA, Vaskina NF, Moseev TD, Varaksin MV, Cha-rushin VN, Chupakhin ON. Metal-Free Eliminative C-H Ar-ylthiolation of 2H-Imidazole N-Oxides with Thiophenols. Chemistry. 2023;5(3):1477–1487. doi:10.3390/chemistry5030100

Vlocskó RB, Mastyugin M, Török B, Török M. Correlation of physicochemical properties with antioxidant activity in phenol and thiophenol analogues. Scientific Reports. 2025;15(1):73. doi:10.1038/s41598-024-83982-4

Fang W-Y, Ravindar L, Rakesh KP, Manukumar HM, Shan-tharam CS, Alharbi NS, Qin H-L. Synthetic approaches and pharmaceutical applications of chloro-containing mole-cules for drug discovery: A critical review. European Jour-nal of Medicinal Chemistry. 2019;173:117–153. doi:10.1016/j.ejmech.2019.03.063

Lavrinchenko IA, Moseev TD, Seleznev YA, Varaksin MV, Tsmokaluk AN, Charushin VN, Chupakhin ON. Blue‐Emitting 2‐Fluoroaryl‐1,2,3‐Triazole Fluorophores: Synthe-sis, Theoretical Calculations, and Optical Properties. Asian Journal of Organic Chemistry. 2023;12(4):e202300008. doi:10.1002/ajoc.202300008

Ritz C, Baty F, Streibig JC, Gerhard D. Dose-response analy-sis using R. PloS One. 2015;10(12):e0146021. doi:10.1371/journal.pone.0146021

Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA, et al. Myogenin, AP2β, NOS-1, and HMGA2 Are Sur-rogate Markers of Fusion Status in Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. American Journal of Surgical Pathology. 2014;38(5):654–659. doi:10.1097/PAS.0000000000000195




DOI: https://doi.org/10.15826/chimtech.9573

Copyright (c) 2026 Vsevolod V. Melekhin, Maria D. Tokhtueva, Igor A. Lavrinchenko, Nikita O. Matyushin, Timofey D. Moseev, Mikhail V. Varaksin, Valery N. Charushin, Oleg N. Chupakhin

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Scopus logo WorldCat logo DOAJ logo CAS logo BASE logo eLibrary logo

Chimica Techno Acta, 2014–2025
eISSN 2411-1414
Copyright Notice